A microbial compound composition for preventing and controlling root rot and its application

By combining multi-strain synergistic antagonism and modified double-layer microcapsule encapsulation technology with protein-based plant immune inducers, the problems of live bacteria storage stability and rhizosphere slow release in the prevention and control of root rot were solved, achieving long-lasting antibacterial effect and plant disease resistance enhancement.

CN123100665APending Publication Date: 2026-11-17INST OF PLANT PROTECTION SICHUAN ACAD OF AGRI SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611095175.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-07-22
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing microbial agents for controlling root rot suffer from problems such as poor stability of live bacteria storage, short rhizosphere slow-release period, insufficient efficacy of single antibacterial mechanisms, and nutrient competition when multiple strains are combined, resulting in poor control stability in field application scenarios.

Method used

A microbial compound composition with synergistic antagonism among multiple strains was used. Through modified double-layer microcapsule encapsulation and combined with protein-based plant immune inducers and immune induction technology, a complementary antagonistic network was formed to synergistically enhance the stability and antibacterial effect of rhizosphere live bacteria.

Benefits of technology

It achieves high encapsulation rate and long-term sustained release of microbial compound composition during room temperature storage, continuously maintains the abundance of rhizosphere antagonistic microorganisms, simultaneously activates multiple plant disease resistance pathways, and enhances the overall disease resistance of crops.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

This invention relates to the field of microbial inoculant preparation technology, and discloses a microbial compound composition for preventing and controlling root rot and its application. Specifically, it is prepared by the following steps: S1, *Bacillus belye*, *Bacillus subtilis*, and *Bacillus amyloliquefaciens* are cultured separately and then mixed in a certain proportion. The products are collected to obtain a compound bacterial strain; S2, the compound bacterial strain is mixed with a protein-based plant immune inducer, loaded and solidified using a modified sodium alginate carrier, and then coated a second time with chitosan solution. The product is collected and dried to obtain a microencapsulated bacterial strain; S3, the microencapsulated bacterial strain is mixed with excipients under sterile conditions, sealed, and stored away from light to obtain a microbial compound composition for preventing and controlling root rot. Through multi-strain synergistic antagonism, modified double-layer microcapsule encapsulation, and combined immune induction technology with a protein-based plant immune inducer, this invention solves the problems of poor live bacteria storage stability, short rhizosphere slow-release period, insufficient efficacy of single antibacterial mechanisms, and nutrient competition in multi-strain compound formulations.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of microbial agent preparation technology, specifically to a microbial compound composition for preventing and controlling root rot and its application. Background Technology

[0002] Crop root rot is caused by the continuous infection of the root system by various soil-borne Fusarium fungi. In continuously cropped fields, soil pathogens accumulate year by year. Conventional control methods are divided into two categories: chemical agents and ordinary microbial agents. Long-term application of chemical fungicides can lead to heavy metal residues in the soil, damage to beneficial microbial communities, and the development of drug resistance in pathogens. Furthermore, the root conduction efficiency of fungicides is low, preventing deep roots from accessing effective agents. The probability of disease recurrence increases significantly during rainy seasons when soil moisture rises. Most commercially available microbial agents use single Bacillus strains, whose metabolites have limited inhibitory range, showing only an inhibitory effect on a few Fusarium species. Their rhizosphere colonization ability is weak, and after application, the live bacteria are rapidly inactivated due to soil pH and competition from native microorganisms, failing to maintain a stable presence around the roots for long periods. Conventional agent carriers often use unmodified sodium alginate, resulting in large pores in the microcapsules. During storage, moisture and oxygen easily penetrate the interior, causing bacterial loss. Soil polysaccharides and proteases rapidly degrade the gel structure, leading to a short-term concentrated release of live bacteria. Subsequently, the lack of antagonistic microorganisms in the rhizosphere to continuously suppress pathogens further exacerbates the problem. Most microbial agents rely solely on bacterial metabolites for inhibition, without incorporating plant immune-activating components. External inhibition alone cannot enhance crop disease resistance, leaving crops without active defense against reinfection. Some products use salicylic acid-based chemical inducers, resulting in a single immune activation pathway, low levels of induced defensive enzymes, and limited overall disease resistance gains. Existing compound microbial agents lack a defined ratio of three Bacillus species, leading to nutrient competition among strains. Mixing these agents reduces the secretion of antagonistic metabolites, failing to form a complementary inhibitory network, resulting in significant fluctuations in disease control after field application. Furthermore, conventional preparation processes lack double-layer coating protection, causing a sharp decline in viable bacterial retention after three months of storage at room temperature. High storage and transportation losses result in insufficient effective viable bacterial doses for farmers, making it difficult to stably control root rot and leading to poor control stability in actual field applications.

[0003] Based on this, this application provides a microbial compound composition for preventing and controlling root rot and its application. Summary of the Invention

[0004] Technical problems to be solved To address the shortcomings of existing technologies, this invention provides a microbial compound composition for the prevention and control of root rot and its application. Through the synergistic antagonism of multiple strains, modified double-layer microcapsule encapsulation, and the synergistic effect of protein-based plant immune inducers combined with immune induction technology, it solves the problems of poor storage stability of live bacteria, short rhizosphere slow-release period, insufficient efficacy of single antibacterial mechanisms, and nutrient competition in multi-strain compound formulations.

[0005] Technical solution To achieve the above objectives, the present invention provides the following technical solution: A microbial compound composition for preventing and controlling root rot is prepared by the following steps: S1. After separately culturing Bacillus berleis, Bacillus subtilis and Bacillus amyloliquefaciens, they were mixed in a certain proportion and the products were collected to obtain a compound strain. S2. The composite bacterial strain was mixed with a protein-based plant immune inducer and then loaded and solidified using a modified sodium alginate carrier. It was then coated a second time with chitosan solution. The product was collected and dried to obtain the microencapsulated bacterial strain. S3. Mix the microencapsulated bacterial strains with excipients under aseptic conditions, seal and store in the dark to obtain a microbial compound composition for preventing root rot.

[0006] Further, in step S1, the Bacillus velezensis specifically refers to Bacillus velezensis BVZ0942, which is deposited at the China Center for Type Culture Collection (CCTCC) with accession number CCTCC NO: M20231560 and a deposit date of August 31, 2023.

[0007] Further, in step S1, Bacillus belye, Bacillus subtilis and Bacillus amyloliquefaciens are mixed in a viable cell ratio of (1-2):(1-2):1.

[0008] In the above technical solution, the combination of Bacillus vesiculosus BVZ0942, Bacillus subtilis, and Bacillus amyloliquefaciens forms a complementary antagonistic network. BVZ0942 has broad-spectrum inhibitory activity against a variety of pathogens, while Bacillus subtilis and Bacillus amyloliquefaciens enhance the rhizosphere microecological advantage by secreting lipopeptide antibiotics and competitively colonizing, respectively. The combination of the three can broaden the antibacterial spectrum and enhance the competitiveness of rhizosphere colonization.

[0009] Further, in step S1, the specific operation of mixing the separately cultured samples in a certain proportion is as follows: Bacillus belye, Bacillus subtilis and Bacillus amyloliquefaciens were removed from glycerol tubes, streaked on LB plates, and incubated at 30°C for 24-48 h. Then, single colonies were picked and inoculated into LB liquid medium and cultured at 30°C and 180 r / min for 24 h to obtain seed culture of each strain. Seed cultures of each strain were subjected to submerged liquid fermentation on LB medium at 30°C and a shaking rate of 180 r / min until the highest viable count of each strain reached 1×10⁻⁶. 9 After CFU / mL, mix under aseptic conditions.

[0010] Furthermore, in step S2, the protein-based plant immune inducer is at least one of hypersensitive protein and cryptoglobin.

[0011] Furthermore, in step S2, the mass ratio of the compound bacterial strain to the protein-based plant immune induction is 100:(1-5).

[0012] Further, in step S2, the modified sodium alginate carrier is specifically prepared by the following steps: A1. Dissolve chitosan in a 2% acetic acid solution to prepare a 1%-3% (w / v) chitosan solution. Add chitosanase to the solution and degrade at 40-50℃ for 1-4 hours. After degradation, heat to 80-90℃ and maintain for 10-15 minutes to inactivate the enzyme, thus obtaining a chitosan / chitooligosaccharide mixed degradation solution. A2. Dissolve sodium alginate in deionized water to prepare a 2.0%-2.5% (w / v) sodium alginate solution; mix the chitosan / chitosan oligosaccharide mixed degradation solution obtained in A1 with the sodium alginate solution at a volume ratio of 1:5 to 1:10, stir evenly, and obtain the modified sodium alginate carrier.

[0013] In the above technical solution, in step A1, a mixed solution containing chitosan oligosaccharide and chitosan is obtained through controlled degradation. In step A2, sodium alginate and chitosan form a polyelectrolyte complex through electrostatic interaction, which can enhance the mechanical strength and structural stability of the carrier. Meanwhile, chitosan oligosaccharide, as a small molecule oligosaccharide, is retained in the carrier matrix and synergistically activates the plant immune pathway with the subsequently added protein-based plant immune inducers.

[0014] Furthermore, in step A1, the amount of chitosanase added is 10-50 U / g chitosan.

[0015] Furthermore, in step S2, the specific operation of load curing is as follows: The composite bacterial strain containing protein-based plant immune inducers in S1 is mixed with the modified sodium alginate solution at a volume ratio of 1:2-3. After stirring evenly, the mixture is dripped dropwise into a 1.5%-2.0% (w / v) sterile calcium chloride solution using a syringe or dropper and solidified for 30-60 minutes to form calcium alginate gel microspheres. Then, it is rinsed 2-3 times with sterile water.

[0016] In this process, sodium alginate cross-links with calcium ions to form a three-dimensional network gel structure, which encapsulates the bacteria and the inducer inside, achieving preliminary immobilization.

[0017] Further, in step S2, the chitosan solution uses acetic acid as a solvent, with a mass concentration of 0.4%-1.0% (w / v), and the pH is adjusted to 5.5-6.0 with NaOH.

[0018] Further, in step S2, the specific operation of the secondary coating is as follows: the solidified microcapsules are transferred into a chitosan solution, stirred slowly at room temperature for 20-40 minutes, then filtered and collected, and rinsed with sterile water.

[0019] In the above technical solution, chitosan carries a positive charge and forms a polyelectrolyte membrane layer through electrostatic adsorption with calcium alginate gel, which carries a negative charge on its surface. This membrane layer can fill the pores on the surface of the microcapsules and further slow down the release rate of bacterial cells and protein-based plant immune inducers.

[0020] Further, in step S2, the specific drying operation is as follows: the microcapsules after secondary coating are laid flat on a sterile tray, pre-frozen in a 4°C refrigerator for 12-24 hours, and then freeze-dried to constant weight.

[0021] Furthermore, in step S3, the excipient is at least one of diatomaceous earth, microporous silica gel, and starch.

[0022] Furthermore, in step S3, the mass ratio of microencapsulated bacterial strains to excipients is 1:(1-3).

[0023] The application of the microbial compound composition obtained in the aforementioned technical solution in the prevention and control of crop root rot caused by Fusarium.

[0024] Beneficial technical effects In the technical solution of this invention, a broad-spectrum antagonistic system is constructed by combining multiple strains. Three types of Bacillus are mixed and cultured according to a limited ratio of live bacteria. There is no nutrient competition between the strains. Each strain secretes different types of lipopeptide antibacterial substances, forming a complementary antagonistic network, which broadens the inhibition range against multiple root-rot Fusarium fungi. Different strains respectively enhance the rhizosphere colonization competition ability and pathogen lysis ability, and synergistically reduce the initial infection base of root pathogens. A single strain or an unbalanced system does not have the multiple antibacterial superposition effect.

[0025] In the technical solution of this invention, a modified sodium alginate composite carrier is combined with a double-layer membrane structure. Chitosan oligosaccharide is introduced into the matrix to fill the pores, and the outer chitosan cationic membrane seals the surface channels of the microcapsules. The dual structure reduces the oxygen and water permeation rate during storage, reduces metabolic loss during the dormancy process of bacteria, and extends the storage period of the finished product at room temperature and away from light. At the same time, it slows down the enzymatic hydrolysis rate of the gel matrix in the soil environment, realizes the phased and long-term release of rhizosphere live bacteria, and continuously maintains the abundance of antagonistic microorganisms around the roots. A single-layer unmodified carrier cannot simultaneously achieve the dual functions of high encapsulation rate and long-term sustained release.

[0026] In the technical solution of this invention, protein-based plant immune inducers and microbial strains form a synergistic internal and external disease resistance mechanism. Bacillus continuously inhibits the proliferation of pathogens in the rhizosphere, and protein elicitors transmit immune signals to the plant, continuously inducing the synthesis and accumulation of multiple defense enzymes, simultaneously activating multiple plant disease resistance pathways, and enhancing the overall disease resistance of crop roots and aboveground tissues. Relying solely on bacterial inhibition or chemical inducers can only achieve single-dimensional disease control, lacking the plant's own active disease resistance enhancement. Detailed Implementation

[0027] To make the objectives, technical solutions, and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention are described clearly and completely. Obviously, the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0028] The raw materials used in the specific embodiments of the present invention are shown below, and all reagents used are analytical grade.

[0029] Chitosan: Manufacturer: Shandong Haidebei Biotechnology Co., Ltd., Model: HD-95. Chitosanase: CAS No. 51570-20-8. Sodium alginate: Viscosity 200 mPa·s. Hypersensitive protein: Nanjing Ruiyuan Biotechnology, Product No. RY-D6003. Cryptoprotein: Nanjing Ruiyuan Biotechnology, Product No. RY-D6005. Diatomaceous earth: Linqu County Runda Diatomaceous Earth Factory, Agricultural carrier grade 800 mesh; Fine-porous silica gel: Qingdao Haiyang Chemical, Type A 3~5mm; Corn starch: COFCO Group food grade corn starch. Bacillus subtilis: CAS No. 68038-70-0. Bacillus amyloliquefaciens: CAS No. 54451-25-1.

[0030] Example 1 The microbial compound composition for preventing and controlling root rot in this embodiment is prepared by the following steps: S1. *Bacillus belye* BVZ0942, *Bacillus subtilis*, and *Bacillus amyloliquefaciens* (CCTCC NO: M 20231560) were cultured separately at a viable count ratio of 1:1:1, and then mixed in a specific ratio. First, the three strains were removed from glycerol tubes and streaked onto LB agar plates, incubated at 30°C for 36 hours. Then, single colonies were picked and inoculated at 1% v / v into LB liquid medium containing 10 g / L tryptone, 5 g / L yeast extract, 10 g / L sodium chloride, and pH 7.0. The medium was incubated at 30°C with shaking at 180 rpm for 24 hours to obtain seed culture for each strain. The seed culture of each strain was then subjected to submerged liquid fermentation on LB medium at 30°C, a shaking rate of 180 rpm, a total aeration rate of 1.0 vvm, and dissolved oxygen maintained above 20%. Fermentation continued until the highest viable count of each strain reached 1 × 10⁻⁶. 9 After mixing CFU / mL, the mixture was aseptically combined, and the product was collected to obtain a composite strain. S2. First, prepare the modified sodium alginate carrier. The specific operation is as follows: A1. Dissolve chitosan with a degree of deacetylation >90% in a 2% acetic acid solution to prepare a 2% (w / v) chitosan solution. Add chitosanase to the solution at a dosage of 30 U / g chitosan. Degrade at 45℃ for 2.5 hours. After degradation, heat to 85℃ and hold for 12 minutes to inactivate the enzyme. Cool to room temperature at a rate of 1℃ / min to obtain a chitosan / chitooligosaccharide mixed degradation solution. A2. Dissolve sodium alginate in deionized water to prepare a 2.2% (w / v) sodium alginate solution. Mix the chitosan / chitooligosaccharide mixed degradation solution obtained in A1 with the sodium alginate solution at a volume ratio of 1:8 and stir evenly to obtain a modified sodium alginate carrier. Then, mix the composite bacterial strain with hypersensitive protein at a mass ratio of 100:3. Mix the composite bacterial strain mixed with protein-based plant immune inducers with the modified sodium alginate solution at a volume ratio of 1:2.5 and stir evenly. Then, use a dropper to add the mixture dropwise to a 1.8% (w / v) sterile calcium chloride solution and solidify for 45 minutes to form a sea... Calcium alginate gel microspheres were then rinsed three times with sterile water. Subsequently, a chitosan solution with a mass concentration of 0.7% (w / v), using acetic acid as a solvent and adjusting the pH to 5.8 with NaOH was used as a secondary coating solution. The solidified microcapsules were transferred into this chitosan solution and slowly stirred at room temperature and 80 rpm for 30 minutes. The microcapsules were then collected by filtration and rinsed three times with sterile water. Finally, the microcapsules with secondary coating were spread evenly on a sterile tray and pre-frozen in a 4°C freezer for 18 hours. Then, the vacuum degree was set to 10 Pa and the cold trap temperature was -55°C, and the samples were freeze-dried until the sample reached constant weight to obtain microencapsulated bacterial strains. S3. Under sterile conditions, the microencapsulated bacterial strains and diatomaceous earth are mixed evenly at a mass ratio of 1:2, sealed, and stored away from light to obtain a microbial compound composition for preventing root rot.

[0031] Example 2 The microbial compound composition for preventing and controlling root rot in this embodiment is prepared by the following steps: S1. *Bacillus belye* BVZ0942, *Bacillus subtilis*, and *Bacillus amyloliquefaciens* (CCTCC NO: M 20231560) were cultured separately at a viable count ratio of 2:1:1, and then mixed in a specific ratio. First, the three strains were removed from glycerol tubes and streaked onto LB agar plates, incubated at 30°C for 24 hours. Then, single colonies were picked and inoculated at 1% v / v into LB liquid medium containing 10 g / L tryptone, 5 g / L yeast extract, 10 g / L sodium chloride, and pH 7.0. The medium was incubated at 30°C with shaking at 180 rpm for 24 hours to obtain seed culture for each strain. The seed culture of each strain was then subjected to submerged liquid fermentation on LB medium at 30°C, a shaking rate of 180 rpm, a total aeration rate of 1.0 vvm, and dissolved oxygen maintained above 20%. Fermentation continued until the highest viable count of each strain reached 1 × 10⁻⁶. 9 After mixing CFU / mL, the mixture was aseptically combined, and the product was collected to obtain a composite strain. S2. First, prepare the modified sodium alginate carrier. The specific steps are as follows: A1. Dissolve chitosan with a degree of deacetylation >90% in a 2% acetic acid solution to prepare a 1% (w / v) chitosan solution. Add chitosanase to the solution at a concentration of 10 U / g chitosan. Degrade the chitosan at 40°C for 4 hours. After degradation, heat the solution to 80°C and hold for 15 minutes to inactivate the enzyme. Cool the solution to room temperature at a rate of 1°C / min to obtain a chitosan / chitooligosaccharide mixed degradation solution. A2. Dissolve sodium alginate in deionized water to prepare a 2.0% (w / v) sodium alginate solution. Mix the chitosan / chitosan oligosaccharide mixed degradation solution obtained in A1 with the sodium alginate solution at a volume ratio of 1:5 and stir evenly to obtain the modified sodium alginate carrier. The compound bacterial strain and cryptogerin were mixed at a mass ratio of 100:1. The compound bacterial strain mixed with protein-based plant immune inducers was mixed with modified sodium alginate solution at a volume ratio of 1:2. After stirring evenly, the mixture was dripped into a 1.5% (w / v) sterile calcium chloride solution using a syringe and solidified for 60 minutes to form calcium alginate gel microspheres. The microspheres were then rinsed twice with sterile water. Subsequently, a chitosan solution with a mass concentration of 0.4% (w / v) using acetic acid as a solvent and pH adjusted to 5.5 with NaOH was used as a secondary coating solution. The solidified microcapsules were transferred into the chitosan solution and slowly stirred at room temperature and 80 rpm for 40 minutes. The microcapsules were then collected by filtration and rinsed twice with sterile water. Finally, the microcapsules with secondary coating were spread evenly on a sterile tray and pre-frozen in a 4°C freezer for 12 hours. Then, the vacuum degree was set to 10 Pa and the cold trap temperature was -55°C, and the samples were freeze-dried until the sample reached constant weight to obtain the microencapsulated bacterial strain. S3. Under aseptic conditions, microencapsulated bacterial strains and fine-pore silica gel are mixed evenly at a mass ratio of 1:1, sealed, and stored away from light to obtain a microbial compound composition for preventing root rot.

[0032] Example 3 The microbial compound composition for preventing and controlling root rot in this embodiment is prepared by the following steps: S1. *Bacillus belye* BVZ0942, *Bacillus subtilis*, and *Bacillus amyloliquefaciens* (CCTCC NO: M 20231560) were cultured separately at a viable count ratio of 2:2:1, and then mixed in a specific ratio. First, the three strains were removed from glycerol tubes and streaked onto LB agar plates, incubated at 30°C for 48 hours. Then, single colonies were picked and inoculated at 1% v / v into LB liquid medium containing 10 g / L tryptone, 5 g / L yeast extract, 10 g / L sodium chloride, and pH 7.0. The medium was incubated at 30°C with shaking at 180 rpm for 24 hours to obtain seed culture for each strain. The seed culture of each strain was then subjected to submerged liquid fermentation on LB medium at 30°C, a shaking rate of 180 rpm, a total aeration rate of 1.0 vvm, and dissolved oxygen maintained above 20%. Fermentation continued until the highest viable count of each strain reached 1 × 10⁻⁶. 9 After mixing CFU / mL, the mixture was aseptically combined, and the product was collected to obtain a composite strain. S2. First, prepare the modified sodium alginate carrier. The specific steps are as follows: A1. Dissolve chitosan with a degree of deacetylation >90% in a 2% acetic acid solution to prepare a 3% (w / v) chitosan solution. Add chitosanase to the solution at a concentration of 50 U / g chitosan. Degrade the chitosan at 50°C for 1 hour. After degradation, heat the solution to 90°C and hold for 10 minutes to inactivate the enzyme. Cool the solution to room temperature at a rate of 1°C / min to obtain a chitosan / chitooligosaccharide mixed degradation solution. A2. Dissolve sodium alginate in deionized water to prepare a 2.5% (w / v) sodium alginate solution. Mix the chitosan / chitosan oligosaccharide mixed degradation solution obtained in A1 with the sodium alginate solution at a volume ratio of 1:10 and stir evenly to obtain the modified sodium alginate carrier. Next, the compound bacterial strain was mixed with a mixture of hypersensitive protein and cryptoglobin (mass ratio 1:1) at a mass ratio of 100:5. The compound bacterial strain containing the protein-based plant immune inducer was then mixed with a modified sodium alginate solution at a volume ratio of 1:3. After stirring thoroughly, the mixture was dripped dropwise into a 2.0% (w / v) sterile calcium chloride solution and solidified for 30 minutes to form calcium alginate gel microspheres. These microspheres were then rinsed three times with sterile water. Finally, a 1.0% (w / v) solution of ethyl acetate was added... A chitosan solution with acid as solvent and pH adjusted to 6.0 by NaOH was used as the secondary coating solution. The solidified microcapsules were transferred into the chitosan solution and stirred slowly at room temperature and 80 rpm for 20 minutes. The microcapsules were then collected by filtration and rinsed three times with sterile water. Finally, the microcapsules with secondary coating were spread on a sterile tray and pre-frozen in a 4°C freezer for 24 hours. Then, the vacuum degree was set to 10 Pa and the cold trap temperature was set to -55°C, and the samples were freeze-dried until the sample reached constant weight to obtain the microencapsulated bacterial strain. S3. Under aseptic conditions, microencapsulated bacterial strains and starch are mixed evenly at a mass ratio of 1:3, sealed, and stored away from light to obtain a microbial compound composition for preventing root rot.

[0033] Comparative Example 1 The difference between this comparative example and Example 1 is that only Bacillus belyss BVZ0942 single strain was used, without the addition of Bacillus subtilis and Bacillus amyloliquefaciens. The specific operation of step S1 is as follows: S1. Remove *Bacillus belye* BVZ0942 (CCTCC NO: M 20231560) from the glycerol tube, streak it on an LB agar plate, and incubate at 30°C for 36 h. Then, pick single colonies and inoculate them at a 1% v / v rate into LB liquid medium containing 10 g / L tryptone, 5 g / L yeast extract, 10 g / L sodium chloride, and pH 7.0. Incubate at 30°C with shaking at 180 rpm for 24 h to obtain the seed culture. Then, perform submerged liquid fermentation on LB medium at 30°C, shaking rate of 180 rpm, a total aeration rate of 1.0 vvm, and dissolved oxygen maintained above 20%. Continue fermentation until the maximum viable count reaches 1 × 10⁻⁶. 9 After collecting the CFU / mL product, a single bacterial strain was obtained.

[0034] Comparative Example 2 The difference between this comparative example and Example 1 is that the live cell ratio of Bacillus belyssus, Bacillus subtilis, and Bacillus amyloliquefaciens is changed to 4:1:1, and the specific operation of step S1 is as follows: The three strains were activated and seed cultures were prepared separately, following the same method as S1 in Example 1. The process continued until the highest viable count of each strain reached 1 × 10⁻⁶. 9 After CFU / mL, the mixture was aseptically prepared at a live bacteria ratio of 4:1:1, and the product was collected to obtain a composite strain.

[0035] Comparative Example 3 The difference between this comparative example and Example 1 is that unmodified sodium alginate carrier is used, and the chitosan enzymatic modification in step A1 is not performed. In specific operation, step A1 is omitted when preparing the carrier. Sodium alginate is directly dissolved in deionized water to prepare a 2.2% (w / v) sodium alginate solution as the carrier, without adding any chitosan or chitosan oligosaccharide components. The composite strain and hypersensitive protein are mixed at a mass ratio of 100:3, and then mixed with the unmodified sodium alginate solution at a volume ratio of 1:2.5. The chitosan solution is still used for subsequent solidification and secondary coating.

[0036] Comparative Example 4 The difference between this comparative example and Example 1 is that the secondary chitosan coating step is omitted, and the microspheres are directly dried after curing. Specifically, the cured calcium alginate gel microspheres are not coated with chitosan solution twice, but are directly rinsed three times with sterile water and then spread on a sterile tray for freeze-drying. The freeze-drying process involves pre-freezing for 18 hours under a vacuum of 10 Pa and a cold trap temperature of -55°C until constant weight is achieved, resulting in microencapsulated bacterial cultures.

[0037] Comparative Example 5 The difference between this comparative example and Example 1 is that no hypersensitive protein is added to the composite bacterial strain. Specifically, in step S2, the composite bacterial strain is mixed with a modified sodium alginate solution without adding any protein-based immune inducers, while the subsequent curing, secondary coating, and drying operations remain unchanged.

[0038] Comparative Example 6 The difference between this comparative example and Example 1 is that the hypersensitive protein was replaced with an equal mass of a conventional chemical inducer, which was salicylic acid.

[0039] The products prepared in the examples and comparative examples are now subjected to performance testing. The specific testing methods are as follows: (1) Microcapsule encapsulation rate determination. Weigh 1.0 g of microencapsulated bacterial sample and place it in a centrifuge tube containing 9 mL of sterile physiological saline. Shake thoroughly to completely break down the microcapsules and release the internal bacteria. Count the number of released viable bacteria using the serial dilution plate method. Take another batch of the same batch of compound bacterial stock solution and determine the total number of viable bacteria using the same serial dilution plate method. Encapsulation rate (%) = (number of viable bacteria released from microcapsules / total number of viable bacteria in the compound bacterial stock solution) × 100%. Each sample was tested in triplicate, and the average value was taken.

[0040] The specific test results are shown in Table 1 below.

[0041] Table 1

[0042] As shown in Table 1, the basic encapsulation levels of each group of examples were similar to those of most comparative examples. Only the comparative example that removed the sodium alginate modification step showed a significant decrease in encapsulation level, while the encapsulation index of the other single-variable adjustment groups did not fluctuate significantly. When sodium alginate was not modified by blending chitosan and chitosan oligosaccharides, the porous structure of the sodium alginate gel network was loose, and leakage easily occurred during the cross-linking process of the bacterial and protein-based plant immune inducer mixture. The lack of small-molecule oligosaccharides to fill the pores inside the carrier matrix prevented the internal active components from being bound by electrostatic forces, directly reducing the encapsulation retention efficiency. Variables such as fine-tuning the ratio of the three bacteria, removing the secondary coating, using protein-based plant immune inducers, and using single bacteria only changed the outer membrane structure of the microcapsules or the types of internal active substances, without affecting the basic retention capacity of the calcium alginate gel, and therefore did not have a significant impact on the encapsulation rate.

[0043] (2) Viable cell retention rate determination. Each sample was sealed and stored in a 25℃ constant temperature incubator away from light. Samples were taken on days 0, 30, 60, and 90, with 1.0 g of sample weighed. Under aseptic conditions, the microcapsules were ruptured, serially diluted, and plated for viable cell count. Viable cell retention rate (%) = (Number of viable cells on day n / Number of viable cells on day 0) × 100%. Each time point was repeated three times. Specific test results are shown in Table 2 below.

[0044] Table 2

[0045] In Table 2, the viable cell retention levels in the three sets of examples remained stable throughout the entire process. In the two comparative groups (unmodified carrier and those without secondary chitosan coating), the decline in viable cell count continued to increase with prolonged storage time. The viable cell decline trends in the comparative groups with other variable adjustments were not significantly different from the examples. The unmodified sodium alginate carrier had interconnected pores, allowing external moisture and oxygen to directly penetrate into the gel during storage, leading to inactivation of spore-forming bacteria due to prolonged exposure to an oxidative environment. Microcapsules without secondary chitosan coating relied solely on a single layer of calcium alginate gel to block the external environment, and the surface pores could not be sealed, resulting in increased metabolic loss of bacteria during long-term storage. The modified sodium alginate matrix, with its own chitosan oligosaccharides filling the pores and an outer chitosan cation membrane sealing the surface pores of the microcapsules, formed a double-layer barrier structure, reducing the rate of oxygen and moisture diffusion and delaying the metabolic consumption of dormant bacteria.

[0046] (3) Determination of sustained-release performance. 2.0 g of sample was weighed and placed in a 100 mL Erlenmeyer flask containing 50 g of sterile soil. The soil moisture content was adjusted to 60% of field capacity, and the flask was incubated at 25℃. 1.0 g samples were taken on days 1, 3, 7, 14, 21, 28, 35, 42, 49, 56, 63, and 70, and serially diluted and plated to count the number of viable bacteria released. Release curves were plotted, and the release duration was recorded. Specific test results are shown in Table 3 below.

[0047] Table 3

[0048] In Table 3, the overall sustained-release period of the examples was longer, while the release period of live bacteria in the unmodified carrier and non-secondary-coated comparative examples was significantly shortened, and the differences in sustained-release time among the other groups were small. Unmodified sodium alginate gel rapidly degrades under the action of soil moisture and microbial enzymes, releasing all internal bacteria in a short time, thus failing to provide a long-term supply. Without the outer chitosan coating, proteases and polysaccharides in the soil matrix directly contact the calcium alginate microspheres, accelerating gel matrix disintegration. After concentrated release, the bacteria are rapidly consumed by indigenous soil microorganisms. In the modified sodium alginate matrix, chitosan and sodium alginate form a polyelectrolyte complex, improving the gel's resistance to soil enzymatic degradation. The outer chitosan membrane can delay the infiltration of soil moisture, achieving a phased, slow disintegration and release of live bacteria.

[0049] (4) Potted plant efficacy test. The root rot pathogen of Sichuan pepper (Fusarium solani) was used as the target pathogen. After activation by inoculating the pathogen onto PDA plates, a spore suspension (1×10⁻⁶) was prepared. 6The spores ( / mL) were mixed evenly with sterilized soil at a ratio of 5% and placed in flowerpots. Healthy tomato seedlings (4-5 leaf stage) with uniform growth were transplanted into pots, one seedling per pot. On the 3rd day after transplanting, 5g of each sample was applied to the rhizosphere soil. A blank control group (no inoculant applied) and a positive control group (applied with an equal volume of unencapsulated compound inoculant stock solution) were set up. Each group had 10 seedlings, and the results were repeated 3 times. The disease incidence was investigated 30 days after transplanting, and the disease index and control effect were calculated. Disease index = ∑(number of diseased plants × representative value) / (total number of plants × highest representative value) × 100. Control effect (%) = (disease index of blank control group - disease index of treatment group) / disease index of blank control group × 100%. The specific test results are shown in Table 4 below.

[0050] Table 4

[0051] As shown in Table 4, the three groups of examples had the lowest disease index and the best control efficacy. The blank control, which had no antibacterial components, had the most severe disease. The positive control without encapsulated compound bacterial stock solution had a significantly lower control efficacy than all microcapsule treatment groups. The control efficacy decreased sequentially from single bacteria, imbalanced strain ratio, lack of modified carrier, lack of secondary encapsulation, removal of protein-based plant immune inducers, to replacement of chemical inducers. Single Bacillus belyceae lacks the complementary antagonistic metabolites of the other two Bacillus species, resulting in insufficient rhizosphere colonization competition and a narrowed antibacterial spectrum. An imbalanced ratio of the three bacteria disrupts the complementary balance of metabolites among strains, reducing the integrity of the antagonistic network. The lack of modified carrier and secondary encapsulation leads to rapid loss of viable bacteria, resulting in a persistently low concentration of effective viable bacteria in the rhizosphere. Removing protein-based immune inducers or replacing them with chemical salicylic acid fails to simultaneously activate the plant's own defense pathways, relying solely on the antibacterial effect of the strain, resulting in a single control mechanism.

[0052] (5) Determination of defensive enzyme activities. Leaves of tomato plants from each treatment group were collected on days 7, 14, and 21 after fungal application to determine the activities of phenylalanine ammonia-lyase (PAL), peroxidase (POD), and polyphenol oxidase (PPO). PAL activity was determined by colorimetric method (expressed as cinnamic acid production), POD activity by guaiacol method, and PPO activity by catechol method. Specific test results are shown in Table 5 below.

[0053] Table 5

[0054] In Table 5, the activities of the three types of defense enzymes in the plants of the example remained high overall. A slight decrease in enzyme activity was observed in the comparative groups where protein-based plant immune inducers were removed and those where chemical inducers were replaced. Protein-based hypersensitive proteins and cryptogenic proteins can specifically recognize plant cell membrane receptors. The salicylic acid and jasmonic acid dual immune pathways were activated, continuously inducing the synthesis and accumulation of PAL, POD, and PPO; chemical salicylic acid only activated the salicylic acid pathway, and its immune induction strength was weaker than that of the protein elicitor.

[0055] It should be noted that, in this document, the terms "comprising," "including," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such a process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising one..." does not exclude the presence of other identical elements in the process, method, article, or apparatus that includes said element.

[0056] The above embodiments are only used to illustrate the technical solutions of the present invention, and are not intended to limit it. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some of the technical features. Such modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the spirit and scope of the technical solutions of the embodiments of the present invention.

[0057] Those skilled in the art should understand that the above descriptions are merely several specific embodiments of the present invention, and not all embodiments.

Claims

1. A microbial compound composition for preventing and controlling root rot, characterized in that, Specifically, it is prepared by the following steps: S1. After separately culturing Bacillus berleis, Bacillus subtilis and Bacillus amyloliquefaciens, they were mixed in a certain proportion and the products were collected to obtain a compound strain. S2. The composite bacterial strain was mixed with a protein-based plant immune inducer and then loaded and solidified using a modified sodium alginate carrier. It was then coated a second time with chitosan solution. The product was collected and dried to obtain the microencapsulated bacterial strain. S3. Mix the microencapsulated bacterial strains with excipients under aseptic conditions, seal and store in the dark to obtain a microbial compound composition for preventing root rot.

2. The microbial compound composition for preventing and controlling root rot according to claim 1, characterized in that, The specific Bacillus belyssus is BVZ0942, which is deposited at the China Center for Type Culture Collection (CCTCC) with accession number CCTCC NO: M 20231560.

3. The microbial compound composition for preventing and controlling root rot according to claim 1, characterized in that, In step S1, Bacillus berreatus, Bacillus subtilis and Bacillus amyloliquefaciens are mixed in a live cell ratio of (1-2):(1-2):

1.

4. The microbial compound composition for preventing and controlling root rot according to claim 1, characterized in that, Bacillus belye, Bacillus subtilis and Bacillus amyloliquefaciens were taken out of glycerol tubes, streaked on LB plates and cultured for 24-48 h. Then, single colonies were picked and inoculated into LB liquid medium and cultured with shaking to obtain seed culture of each strain. Seed cultures of each strain were subjected to liquid submerged fermentation on LB medium until the highest viable count of each strain reached 1×10⁻⁶. 9 After CFU / mL, mix under aseptic conditions.

5. The microbial compound composition for preventing and controlling root rot according to claim 1, characterized in that, In step S2, the protein-based plant immune inducer is at least one of hypersensitive protein and cryptoglobin.

6. The microbial compound composition for preventing and controlling root rot according to claim 1, characterized in that, In step S2, the mass ratio of the compound bacterial strain to the protein-based plant immune induction is 100:(1-5).

7. The microbial compound composition for preventing and controlling root rot according to claim 1, characterized in that, In step S2, the modified sodium alginate carrier is specifically prepared by the following steps: A1. Dissolve chitosan in acetic acid solution to prepare chitosan solution, add chitosanase to it, degrade at 40-50℃ for 1-4 hours, after degradation is complete, heat to 80-90℃ and keep for 10-15 minutes to obtain chitosan / chitooligosaccharide mixed degradation solution. A2. Dissolve sodium alginate in deionized water to prepare a sodium alginate solution; mix the chitosan / chitosan oligosaccharide mixed degradation solution obtained in A1 with the sodium alginate solution at a volume ratio of 1:5 to 1:10 to obtain a modified sodium alginate carrier.

8. The microbial compound composition for preventing and controlling root rot according to claim 7, characterized in that, In step A1, the amount of chitosanase added is 10-50 U / g chitosan.

9. The microbial compound composition for preventing and controlling root rot according to claim 1, characterized in that, In step S2, the specific operation of load curing is as follows: The composite bacterial strain containing protein-based plant immune inducers in S1 was mixed with the above-mentioned modified sodium alginate solution at a volume ratio of 1:2-3. After stirring evenly, the mixture was dripped into a sterile calcium chloride solution using a syringe or dropper to solidify and form calcium alginate gel microspheres, which were then rinsed with sterile water.

10. The use of a microbial compound composition as described in any one of claims 1-9 in the prevention and control of crop root rot caused by Fusarium.